Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 3, 2000, Pages 311-319

  Iijima, Akihiro ^a   Tanaka, Eiji ^a   Kobayashi, Masanori ^a   Yagi, Shintaro ^b   Mizokami, Masashi ^c   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tonen Corp   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Core protein; Envelope 2 non structural 1 (E2 NS 1) region; Hepatitis C virus; Histological prognosis; Mutation of nucleotide sequence

Indexed keywords

CORE PROTEIN;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VIREMIA; VIRUS MUTATION;

EID: 0034030431     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02127.x     Document Type: Article

References (33)

1. Alter HJ, Purcell RH, Shin JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute chronic non-A non-B hepatitis. N. Engl. J. Med. 1989; 321: 1494-500.
2. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
3. Saito I, Miyamura T, Tanaka E. Hepatitis C virus infection associated with the development of hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 1990; 87: 6547-9.
4. Tanaka E, Kiyosawa K, Nakatsuji Y et al. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in post-transfusion hepatitis patients during long-term follow-up. J. Med. Virol. 1993; 39: 318-24.
5. Yano M, Kumada H, Kage M et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 19: 1334-40.
6. Enomoto N, Tanaka A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem. Biophys. Res. Commun. 1990; 170: 1021-5.
7. Houghton M, Weiner A, Han J, Kou G, Choo QL. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381-8.
8. Cuypers HTM, Winkel IN, van der Poel CL et al. Analysis of genomic variability of hepatitis C virus. J. Hepatol. 1991; 13 (Suppl. 4): S15-19.
9. Inchauspe G, Zebedee S, Lee DH, Sugitani M, Nasoff M, Prince AM. Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates. Proc. Natl Acad. Sci. USA 1991; 88: 10292-6.
10. Okamoto H, Kurai K, Okada S et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 1992; 188: 331-41.
11. Cha TA, Beall E, Irvine B et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc. Natl Acad. Sci. USA 1992; 89: 7144-8.
12. Simmonds P, McOmish F, Yap PL et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. J. Gen. Virol. 1993; 74: 661-8.
13. Chayama K, Tsubota A, Arase Y et al. Genotypic subtyping of hepatitis C virus. J. Gastroenterol. Hepatol. 1993; 8: 150-6.
14. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-4.
15. Yoshioka K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
16. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 1994; 39: 1273-80.
17. Dusheiko G, Schmilovitz-Weiss H, Brown D et al. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 1993; 19: 13-18.
18. Tanaka E, Kiyosawa K, Matsushima T et al. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver disease: A multi-institution analysis. J. Gastroenterol. Hepatol. 1995; 10: 538-45.
19. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C. A comparison between patients with genotypes 1 and 2 hepatitis C virus. Hepatology 1996; 23: 695-9.
20. Tanaka T, Lau JY, Mizokami M et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J. Hepatol. 1995; 3: 742-5.
21. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347-53.
22. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
23. Desmet VJ, Gerver M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis. Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
24. Cao K, Mizokami M, Orito E et al. Nucleotide and amino acid diversities of E2/NS1 hypervariable lesion 1 and response to interferon therapy in patients with chronic hepatitis C virus infection. Hepatol. Res. 1998; 11: 166-77.
25. Choo QL, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl Acad. Sci. USA 1991; 88: 2451-5.
26. Ogata N. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl Acad. Sci. USA 1991; 88: 3392-6.
27. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
28. Shev S, Dhillon AP, Lindh M et al. The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C. Liver 1997; 17: 215-23.
29. Tanaka E, Kiyosawa K, Matsumoto A et al. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1996; 23: 1330-3.
30. Orito E, Mizokami M, Tanaka T et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 1996; 39: 876-80.
31. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc. Natl Acad. Sci. USA 1992; 89: 3468-72.
32. Kato N, Sekiya H, Otsuyama Y et al. Humoral immune response to hypervariable lesion 1 of the putative envelope glycoprotein of hepatitis C virus. J. Virol. 1993; 67: 3923-30.
33. Yamaguchi K, Tanaka E, Higashi K et al. Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 1994; 106: 1344-8.